Risk factors of readmission in acute exacerbation of moderate-to-severe chronic obstructive pulmonary disease

被引:15
作者
González, C
Servera, E
Ferris, G
Blasco, ML
Marín, J
机构
[1] Univ Valencia, Hosp Clin Univ, Serv Neumol, Valencia, Spain
[2] Hosp Clin Univ, Serv Med Intens, Unidad Coronaria, Valencia, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2004年 / 40卷 / 11期
关键词
chronic obstructive pulmonary disease (COPD); exacerbation; readmission; inspiratory load; pressure-time index;
D O I
10.1157/13067571
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OBJECTIVES: More effective management of chronic obstructive pulmonary disease (COPD) and improved survival of COPD patients requires a better understanding of the risk factors for exacerbation. The aim of this study was to identify factors related to readmission in patients with moderate-to-severe COPD. PATIENTS AND METHODS: Ninety patients with moderate-to-severe COPD hospitalized consecutively for acute exacerbation were studied prospectively. At discharge, the following potential predictors were assessed: clinical and spirometric variables, arterial blood gases, and respiratory muscle strength determined noninvasively. The patients were followed for a period of 3 months. Readmission for exacerbation and time intervals free of hospitalization were recorded. RESULTS: Univariate analysis showed that the presence of cor pulmonale (P<.05), long-term oxygen therapy (P<.05), hypercapnia (P<.05), and high inspiratory load-mean inspiratory airway pressure measured at the mouth exceeding 0.40 cm H2O and a pressure-time index greater than 0.25 (P<.05 for both variables)-increased the risk of hospitalization for exacerbation. Multivariate analysis showed that only cor pulmonale (P<.05) and a high pressure-time index (>0.25, P<.05) were independently related to risk of readmission. CONCLUSIONS: Cor pulmonale and a high pressure-time index are independent risk factors for hospitalization for exacerbation of moderate-to-severe COPD.
引用
收藏
页码:502 / 507
页数:6
相关论文
共 29 条
[1]   Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD [J].
Adams, SG ;
Melo, J ;
Luther, M ;
Anzueto, A .
CHEST, 2000, 117 (05) :1345-1352
[2]  
Altose MD, 2000, NEW ENGL J MED, V343, P1902
[3]  
American Thoracic Society, 1995, AM J RESP CRIT CARE, V152, P77
[4]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[5]  
BALL P, 1995, QJM-INT J MED, V88, P61
[6]   FORCE RESERVE OF THE DIAPHRAGM IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
BELLEMARE, F ;
GRASSINO, A .
JOURNAL OF APPLIED PHYSIOLOGY, 1983, 55 (01) :8-15
[7]  
BLACK LF, 1969, AM REV RESPIR DIS, V99, P696
[8]   Functional status and survival following pulmonary rehabilitation [J].
Bowen, JB ;
Votto, JJ ;
Thrall, RS ;
Haggerty, MC ;
Stockdale-Woolley, R ;
Bandyopadhyay, T ;
ZuWallack, RL .
CHEST, 2000, 118 (03) :697-703
[9]   Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].
Burge, PS ;
Calverley, PMA ;
Jones, PW ;
Spencer, S ;
Anderson, JA ;
Maslen, TK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303
[10]   Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial [J].
Calverley, P ;
Pauwels, R ;
Vestbo, J ;
Jones, P ;
Pride, N ;
Gulsvik, A ;
Anderson, J ;
Maden, C .
LANCET, 2003, 361 (9356) :449-456